A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Completed · Phase 2

Conditions studied: Melanoma

In brief

The purpose of this clinical research study is to evaluate the Best Overall Response Rate (BORR), (as per modified WHO criteria) in patients with previously treated melanoma-Stage III (unresectable) or Stage IV melanoma receiving 10 mg/kg of ipilimumab. The safety of this product will also be evaluated.

Key facts

Study ID

NCT00289627

Run by

Bristol-Myers Squibb

People needed

155

Starts

2006-04-01

Expected to finish

2007-07-01

Last updated by the study team

2016-09-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with previously treated Stage III (unresectable)or Stage IV melanoma

Where it is running

• Study site — San Francisco, California, United States
• Study site — Santa Monica, California, United States
• Study site — Chicago, Illinois, United States
• Study site — Park Ridge, Illinois, United States
• Study site — Goshen, Indiana, United States
• Study site — Hazard, Kentucky, United States
• Study site — Albuquerque, New Mexico, United States
• Study site — New York, New York, United States
• Study site — Portland, Oregon, United States
• Study site — Greenville, South Carolina, United States
• Study site — Knoxville, Tennessee, United States
• Study site — Dallas, Texas, United States
• Study site — Charlottesvillle, Virginia, United States
• Local Institution — Salzburg, Austria
• Local Institution — Vienna, Austria
• Local Institution — Wels, Austria
• Local Institution — Turku, Finland
• Local Institution — Genova, Italy
• Local Institution — Meldola, Italy
• Local Institution — Milan, Italy
• Local Institution — Naples, Italy
• Local Institution — Padova, Italy
• Local Institution — Siena, Italy
• Local Institution — Torino, Italy
• Study site — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.